Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.48 USD | +0.47% | +0.14% | +123.52% |
May. 07 | Fusion Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | TD Cowen Downgrades Fusion Pharmaceuticals to Hold | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
- Stock Market
- Equities
- FUSN Stock
- News FUSN PHAR
- Fusion Pharmaceuticals : Names Mohit Rawat as President and Chief Business Officer